Royalty Pharma Taps AlphaSense to Streamline Research Workflows

Royalty Pharma, a biopharmaceutical royalty investment firm, managed vast amounts of data across disconnected sources while needing capacity for due diligence. It implemented AlphaSense's generative AI search, Enterprise Intelligence for internal document integration, and workflow automation. The page states this delivered a 30% reduction in research-workflow time, and let a team of just 3-4 analysts do work equivalent to 100+ people at traditional pharma companies, via a unified searchable knowledge base combining internal and external data.

AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.